📍 April 18, 2026 | Intercontinental Hotel, Sofia
MVIATE was pleased to be part of the organization and implementation of a significant scientific event dedicated to rare tumors - a field that requires a high level of expertise, a multidisciplinary approach and sustainable international cooperation.
🔬 ESMO in Focus: Rare Tumors Bulgaria 2026 brought together leading Bulgarian and international specialists who focused on key topics in modern oncology:
🤝 the importance of collaborations in rare diseases and future perspectives
🇪🇺 European Mission to Fight Cancer and initiatives aimed at rare tumors
🧫 rare subtypes of gastrointestinal, genitourinary and skin tumors
🎯 the role of biomarkers and precision medicine
🔍 Cancer of Unknown Primary (CUP) - diagnostics and therapeutic strategies
💡 innovations in treatment - targeted therapies, ADCs and new molecules
🦴 progress in sarcomas and a multidisciplinary approach to treatment
🫁 rare thoracic tumors and updates to ESMO guidelines
🌐 International participation contributed to the high scientific level of the program:
• Prof. Dr Winette Van der Graaf, MD, PhD focuses on the transition from observational to interventional clinical trials
• Dr Jorge Barriuso presented the latest scientific data on pseudomyxoma peritonei
It is a privilege for us at MVIATE to organize events that create an environment for the exchange of knowledge, expertise and good practices for the benefit of the medical community and patients.
The ESMO-licensed event was distinguished by:
➡️ high level of scientific expertise and international participation
➡️ focus on the patient-centered approach
➡️ emphasis on personalized medicine and innovation
➡️ active discussions and professional exchange
📚 ESMO in Focus: Rare Tumors Bulgaria 2026 emphasized the need for continued development of scientific research, expert dialogue and international cooperation to improve the care of patients with rare tumors.
🙏 We thank all speakers, partners and participants for their trust and contribution to the development of oncology in Bulgaria.